Literature DB >> 703400

Relationship between glucose phosphorylating activities and erythrocyte age.

G Fornaini, M Magnani, M Dachà, M Bossú, V Stocchi.   

Abstract

Glucose phosphorylating activity of human erythrocytes quickly decreases during cell ageing; the electrophoretic pattern suggests that this fast decrease is due mainly to the isozyme II. We have shown that in the young cells only hexokinase I and II are responsible for the glucose phosphorylation, while in the old cells another glucose phosphorylating activity, more evident at high glucose concentration, is also present. The appearance of this activity during cell ageing could be interpreted as a post-translational modification of the native hexokinase.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 703400     DOI: 10.1016/0047-6374(78)90024-6

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  5 in total

1.  Glucose metabolism in fibroblasts from patients with erythrocyte hexokinase deficiency.

Authors:  M Magnani; L Chiarantini; V Stocchi; M Dachà; G Fornaini
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Ca2+ transport activities of inside-out vesicles prepared from density-separated erythrocytes from rat and human.

Authors:  N W Seidler; N I Swislocki
Journal:  Mol Cell Biochem       Date:  1991-07-10       Impact factor: 3.396

3.  Increased HK1 activity levels in the red cells of a patient with a de novo trisomy 10p: t(Y;10)(p11;p12).

Authors:  B Dallapiccola; L Chessa; P Vignetti; E Ferrante; E Gandini
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

4.  Rabbit red blood cell hexokinase. Evidences for an ATP-dependent decay during cell maturation.

Authors:  M Magnani; V Stocchi; M Dachà; G Fornaini
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

5.  Molecular forms of red blood cell hexokinase.

Authors:  G Fornaini; M Dachà; M Magnani; V Stocchi
Journal:  Mol Cell Biochem       Date:  1982-12-10       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.